ABEO Annual Revenue
$3.50 M
+$2.09 M+147.52%
31 December 2023
Summary:
As of January 20, 2025, ABEO annual revenue is $3.50 million, with the most recent change of +$2.09 million (+147.52%) on December 31, 2023. During the last 3 years, it has fallen by -$6.50 million (-65.00%). ABEO annual revenue is now -65.00% below its all-time high of $10.00 million, reached on December 31, 2020.ABEO Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Quarterly Revenue
N/A
30 September 2024
Summary:
ABEO quarterly revenue is not available.ABEO Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO TTM Revenue
N/A
30 September 2024
Summary:
ABEO TTM revenue is not available.ABEO TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABEO Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +147.5% | - | - |
| 3 y3 years | -65.0% | - | - |
| 5 y5 years | +16.7% | - | - |
ABEO Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.5% | ||||
| 5 y | 5-year | -65.0% | +147.5% | ||||
| alltime | all time | -65.0% |
Abeona Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.50 M(+147.5%) | - | - |
| June 2023 | - | $3.50 M(+5047.1%) | $3.57 M(+152.3%) |
| Dec 2022 | $1.41 M(-52.9%) | $68.00 K(-93.2%) | $1.41 M(-67.5%) |
| June 2022 | - | $1.00 M(+189.0%) | $4.35 M(+29.9%) |
| Mar 2022 | - | $346.00 K(-88.5%) | $3.35 M(+11.5%) |
| Dec 2021 | $3.00 M(-70.0%) | $3.00 M(0.0%) | $3.00 M(-70.0%) |
| Dec 2020 | $10.00 M(+233.6%) | $3.00 M(-57.1%) | $10.00 M(+42.9%) |
| Sept 2020 | - | $7.00 M(+1352.3%) | $7.00 M(+133.5%) |
| Dec 2018 | $3.00 M(+258.2%) | $482.00 K(-71.8%) | $3.00 M(+9.8%) |
| Sept 2018 | - | $1.71 M(+519.2%) | $2.73 M(+120.1%) |
| June 2018 | - | $276.00 K(-48.0%) | $1.24 M(+5.0%) |
| Mar 2018 | - | $531.00 K(+147.0%) | $1.18 M(+41.2%) |
| Dec 2017 | $837.00 K(-5.8%) | $215.00 K(-1.8%) | $837.00 K(-4.7%) |
| Sept 2017 | - | $219.00 K(+0.9%) | $878.00 K(+4.2%) |
| June 2017 | - | $217.00 K(+16.7%) | $843.00 K(+0.4%) |
| Mar 2017 | - | $186.00 K(-27.3%) | $840.00 K(-5.5%) |
| Dec 2016 | $889.00 K(-14.5%) | $256.00 K(+39.1%) | $889.00 K(+4.8%) |
| Sept 2016 | - | $184.00 K(-14.0%) | $848.00 K(-10.6%) |
| June 2016 | - | $214.00 K(-8.9%) | $949.00 K(-6.7%) |
| Mar 2016 | - | $235.00 K(+9.3%) | $1.02 M(-2.2%) |
| Dec 2015 | $1.04 M(+12.4%) | $215.00 K(-24.6%) | $1.04 M(-1.8%) |
| Sept 2015 | - | $285.00 K(+1.1%) | $1.06 M(+4.9%) |
| June 2015 | - | $282.00 K(+9.3%) | $1.01 M(+3.6%) |
| Mar 2015 | - | $258.00 K(+10.3%) | $975.00 K(+5.4%) |
| Dec 2014 | $925.00 K(-54.7%) | $234.00 K(-0.8%) | $925.00 K(+8.4%) |
| Sept 2014 | - | $236.00 K(-4.5%) | $853.00 K(+5.8%) |
| June 2014 | - | $247.00 K(+18.8%) | $806.00 K(-21.4%) |
| Mar 2014 | - | $208.00 K(+28.4%) | $1.03 M(-49.8%) |
| Dec 2013 | $2.04 M(-53.6%) | $162.00 K(-14.3%) | $2.04 M(-29.2%) |
| Sept 2013 | - | $189.00 K(-59.5%) | $2.89 M(-19.1%) |
| June 2013 | - | $467.00 K(-61.8%) | $3.57 M(-5.9%) |
| Mar 2013 | - | $1.22 M(+21.7%) | $3.79 M(-13.9%) |
| Dec 2012 | $4.40 M(+139.5%) | $1.01 M(+15.5%) | $4.40 M(+13.0%) |
| Sept 2012 | - | $871.00 K(+26.2%) | $3.90 M(-4.2%) |
| June 2012 | - | $690.00 K(-62.4%) | $4.07 M(+15.3%) |
| Mar 2012 | - | $1.84 M(+268.9%) | $3.53 M(+91.7%) |
| Dec 2011 | $1.84 M | $498.00 K(-52.2%) | $1.84 M(+23.6%) |
| Sept 2011 | - | $1.04 M(+594.0%) | $1.49 M(+159.2%) |
| June 2011 | - | $150.00 K(0.0%) | $574.00 K(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | $150.00 K(+2.0%) | $529.00 K(+10.0%) |
| Dec 2010 | $481.00 K(+36.6%) | $147.00 K(+15.7%) | $481.00 K(+9.8%) |
| Sept 2010 | - | $127.00 K(+21.0%) | $438.00 K(-3.7%) |
| June 2010 | - | $105.00 K(+2.9%) | $455.00 K(+10.2%) |
| Mar 2010 | - | $102.00 K(-1.9%) | $413.00 K(+17.3%) |
| Dec 2009 | $352.00 K(+21.0%) | $104.00 K(-27.8%) | $352.00 K(+9.3%) |
| Sept 2009 | - | $144.00 K(+128.6%) | $322.00 K(+43.1%) |
| June 2009 | - | $63.00 K(+53.7%) | $225.00 K(-23.5%) |
| Mar 2009 | - | $41.00 K(-44.6%) | $294.00 K(+1.0%) |
| Dec 2008 | $291.00 K(+410.5%) | $74.00 K(+57.4%) | $291.00 K(+8.6%) |
| Sept 2008 | - | $47.00 K(-64.4%) | $268.00 K(+18.1%) |
| June 2008 | - | $132.00 K(+247.4%) | $227.00 K(+138.9%) |
| Mar 2008 | - | $38.00 K(-25.5%) | $95.00 K(+66.7%) |
| Dec 2007 | $57.00 K(-95.0%) | $51.00 K(+750.0%) | $57.00 K(+850.0%) |
| Sept 2007 | - | $6000.00(-96.8%) | $6000.00(-97.8%) |
| Sept 2004 | - | $185.00 K(+172.1%) | $273.00 K(+175.8%) |
| June 2004 | - | $68.00 K(+240.0%) | $99.00 K(-86.1%) |
| Mar 2004 | - | $20.00 K(+81.8%) | $714.00 K(-59.5%) |
| Sept 2003 | - | $11.00 K(-98.4%) | $1.76 M(-4.3%) |
| June 2003 | - | $683.00 K(+73.8%) | $1.84 M(+29.5%) |
| Mar 2003 | - | $393.00 K(-41.9%) | $1.42 M(+24.1%) |
| Dec 2002 | $1.15 M(+372.0%) | $677.00 K(+644.0%) | $1.15 M(+138.5%) |
| Sept 2002 | - | $91.00 K(-65.4%) | $481.00 K(+20.0%) |
| June 2002 | - | $263.00 K(+126.7%) | $401.00 K(+170.9%) |
| Mar 2002 | - | $116.00 K(+954.5%) | $148.00 K(-39.1%) |
| Dec 2001 | $243.00 K(+127.1%) | $11.00 K(0.0%) | $243.00 K(+4.7%) |
| Sept 2001 | - | $11.00 K(+10.0%) | $232.00 K(+5.0%) |
| June 2001 | - | $10.00 K(-95.3%) | $221.00 K(+4.2%) |
| Mar 2001 | - | $211.00 K(>+9900.0%) | $212.00 K(+1225.0%) |
| Dec 2000 | $107.00 K(+613.3%) | - | - |
| June 2000 | - | $1000.00(-92.9%) | $16.00 K(0.0%) |
| Dec 1999 | $15.00 K(>+9900.0%) | $14.00 K(+1300.0%) | $16.00 K(+700.0%) |
| Sept 1999 | - | $1000.00(>+9900.0%) | $2000.00(+100.0%) |
| June 1999 | - | $0.00(-100.0%) | $1000.00(0.0%) |
| Mar 1999 | - | $1000.00 | $1000.00 |
| Dec 1998 | $0.00(-100.0%) | - | - |
| Dec 1997 | $435.00 K(+160.5%) | - | - |
| Dec 1996 | $167.00 K(-94.3%) | - | - |
| Dec 1995 | $2.94 M | - | - |
FAQ
- What is Abeona Therapeutics annual revenue?
- What is the all time high annual revenue for Abeona Therapeutics?
- What is Abeona Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Abeona Therapeutics?
- What is the all time high TTM revenue for Abeona Therapeutics?
What is Abeona Therapeutics annual revenue?
The current annual revenue of ABEO is $3.50 M
What is the all time high annual revenue for Abeona Therapeutics?
Abeona Therapeutics all-time high annual revenue is $10.00 M
What is Abeona Therapeutics annual revenue year-on-year change?
Over the past year, ABEO annual revenue has changed by +$2.09 M (+147.52%)
What is the all time high quarterly revenue for Abeona Therapeutics?
Abeona Therapeutics all-time high quarterly revenue is $7.00 M
What is the all time high TTM revenue for Abeona Therapeutics?
Abeona Therapeutics all-time high TTM revenue is $10.00 M